Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-23

Clinical Trial Update: Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II) [NA]

View source ↗

Summary

A completed clinical trial assessed Vesicare (solifenacin) for aiding return to continence after radical prostatectomy; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vesicare (solifenacin succinate)

Snippet

Sponsor: University of California, Irvine | Conditions: Urinary Incontinence | NA | Status: COMPLETED | Results posted: 2014-01-23